|
1
|
Faris Raheem M, Ali SH, Al-Nuaimi AMA and
Shareef GL: Impact of serum vitamin D level on selected
bone-related markers in obese-type 2 diabetes patients. [version 1;
peer review: awaiting peer review]. F1000Research. 12(56)2023.
|
|
2
|
Ali IA and Ali SH: Impact of osteocalcin
level on vascular calcification in type 2 diabetics in relation to
fibroblast growth factor-23 (FGF-23). Iraqi J Pharm Sci. 27:42–54.
2018.
|
|
3
|
Shaheed HS and Ali SH: Association of
carnosinase-1 gene polymorphism with serum carnosine and
carnosinease-1 isoform levels in type 2 diabetics with
cardiovascular diseases in Iraq. Al-Rafidain J Med Sci. 4:109–117.
2023.
|
|
4
|
Kadhim SA, Saleh ES and Jaafer AD:
Assessment of serum levels of advanced oxidation protein products
in type 2 diabetic patients with and without retinopathy taking
different antidiabetic treatments. Iraqi J Pharm Sci. 32:74–82.
2023.
|
|
5
|
Gui F, You Z, Fu S, Wu H and Zhang Y:
Endothelial dysfunction in diabetic retinopathy. Front Endocrinol
(Lausanne). 11(591)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mhaibes SH and Ali SH: Biomarkers of
oxidative stress in diabetic microvascular complications. Iraqi J
Pharm Sci. 33(3)2024.(In press).
|
|
7
|
He F, Ru X and Wen T: NRF2, a
transcription factor for stress response and beyond. Int J Mol Sci.
21(4777)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Xu X, Luo P, Wang Y, Cui Y and Miao L:
Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel
therapeutic target for diabetic complications. J Int Med Res.
41:13–19. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhao Z, Chen Y, Wang J, Sternberg P,
Freeman ML, Grossniklaus HE and Cai J: Age-related retinopathy in
NRF2-deficient mice. PLoS One. 6(e19456)2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xu Z, Wei Y, Gong J, Cho H, Park JK, Sung
ER, Huang H, Wu L, Eberhart C, Handa JT, et al: NRF2 plays a
protective role in diabetic retinopathy in mice. Diabetologia.
57:204–213. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kumar A and Mittal R: Nrf2: A potential
therapeutic target for diabetic neuropathy. Inflammopharmacology.
25:393–402. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dodson M, Shakya A, Anandhan A, Chen J,
Garcia JGN and Zhang DD: NRF2 and diabetes: The good, the bad, and
the complex. Diabetes. 71:2463–2476. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Solomon SD and Goldberg MF: ETDRS grading
of diabetic retinopathy: Still the gold standard? Ophthalmic Res.
62:190–195. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
American Diabetes Association Professional
Practice Committee. 2. Diagnosis and classification of diabetes:
Standards of care in diabetes-2024. Diabetes Care. 47 (Suppl
1):S20–S42. 2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Deliyanti D, Alrashdi SF, Tan SM, Meyer C,
Ward KW, de Haan JB and Wilkinson-Berka JL: Nrf2 activation is a
potential therapeutic approach to attenuate diabetic retinopathy.
Invest Ophthalmol Vis Sci. 59:815–825. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li C, Miao X, Li F, Wang S, Liu Q, Wang Y
and Sun J: Oxidative stress-related mechanisms and antioxidant
therapy in diabetic retinopathy. Oxid Med Cell Longev.
2017(9702820)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sun Y, Xiu C, Liu W, Tao Y, Wang J and Qu
YI: Grape seed proanthocyanidin extract protects the retina against
early diabetic injury by activating the Nrf2 pathway. Exp Ther Med.
11:1253–1258. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cao Y, Li X, Wang CJ, Li P, Yang B, Wang
CB and Wang LX: Role of NF-E2-related factor 2 in neuroprotective
effect of l-carnitine against high glucose-induced oxidative stress
in the retinal ganglion cells. Biomed Pharmacother. 69:345–348.
2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
B Domènech E and Marfany G: The relevance
of oxidative stress in the pathogenesis and therapy of retinal
dystrophies. Antioxidants (Basel). 9(347)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fan J, Xu G, Jiang T and Qin Y:
Pharmacologic induction of heme oxygenase-1 plays a protective role
in diabetic retinopathy in rats. Invest Ophthalmol Vis Sci.
53:6541–6556. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bucolo C, Drago F, Maisto R, Romano GL,
D'Agata V, Maugeri G and Giunta S: Curcumin prevents high glucose
damage in retinal pigment epithelial cells through ERK1/2-mediated
activation of the Nrf2/HO-1 pathway. J Cell Physiol.
234:17295–17304. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kanwar M, Chan PS, Kern TS and Kowluru RA:
Oxidative damage in the retinal mitochondria of diabetic mice:
Possible protection by superoxide dismutase. Invest Ophthalmol Vis
Sci. 48:3805–3811. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Setareh J, Hoseinzade G, Khoundabi B,
Kamali M, Ebrahimi A, Fazlollahpour-Naghibi A, Zareei M,
Mohamaditabar M and Makaremi A: Can the level of HbA1C predict
diabetic retinopathy among type II diabetic patients? BMC
Ophthalmol. 22(415)2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kant D, Kumari J and Singh RK: Correlation
of blood sugar and HbA1C levels in different stage of diabetes
retinopathy: A hospital based prospective study. Int J Health Sci.
6:1867–1876. 2022.
|
|
26
|
Salih BH, Ali SH and Allehibi KI: Serum
aldosterone levels in patients with diabetic nephropathy in
relation to vascular calcification. Iraqi J Pharm Sci. 28:53–63.
2019.
|
|
27
|
Hou Y, Lin M, Qiu X, He M, Zhang Y and Guo
F: Effect of type-2 diabetes mellitus in retinopathy patients on
MDA, SOD activity and its correlation with hba1c. Braz Arch Biol
Technol. 64(e21200075)2022.
|
|
28
|
Filla LA and Edwards JL: Metabolomics in
diabetic complications. Mol Biosyst. 12:1090–1105. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hyttinen JMT, Kannan R, Felszeghy S,
Niittykoski M, Salminen A and Kaarniranta K: The Regulation of
NFE2L2 (NRF2) signalling and epithelial-to-mesenchymal transition
in age-related macular degeneration pathology. Int J Mol Sci.
20(5800)2019.PubMed/NCBI View Article : Google Scholar
|
